Infective dose (ID) and Lethal Dose (LD)

The severity and duration of any infectious disease depend on the infective dose of the pathogen and predisposing host factors.

The infective dose is defined as a minimum number of microorganisms required for an infection to proceed. Some pathogens can cause infection only with a small number of cells in the initial inoculum, whereas others require many cells to infect a host successfully. For example, only about ten cells of EHEC (Enterohemorrhagic Escherichia coli) can cause infection. Whereas Vibrio cholerae requires 10 3 to 10 8 cells.

Table of Contents

Estimated Infective Dose of Selected Pathogens

Microbes with small infective doses have greater virulence. The presence of a suboptimal dose of disease-causing pathogens does not result in infection.

Example: Infective dose of Bacillary Dysentery vs Cholera

Bacillary Dysentery

Shigellae are only pathogenic in humans. The ingestion of pathogens are through oral route. Only a few hundred Shigella bacteria are sufficient for an infective dose.

Cholera

Infection results from oral ingestion of the pathogen. The infective dose must be large (≥10 8 ), since many Vibrios are killed by the hydrochloric acid in gastric juice.

Measurement of Virulence

  1. Infectious dose 50 (ID50) refers to the dose or number of organisms that will infect 50% of an experimental group of hosts within a specified time.
  2. Lethal dose 50 (LD50) refers to the dose or number of organisms that will kill 50% of an experimental group of hosts within a specified time.

In this example, 30 doses of strain A of a pathogen can kill 50% of host cells, whereas, for strain B, 50 doses are required. As a smaller dose of strain A (compared with strain B) can kill 50% population of host cells, strain A is more virulent than strain B.

  1. Chan, T. C., Jiang, J., Temenak, J. J., & Richards, A. L. (2003). Development of a rapid method for determining the infectious dose (ID)50 of Orientia tsutsugamushi in a scrub typhus mouse model for the evaluation of vaccine candidates. Vaccine, 21(31), 4550–4554. https://doi.org/10.1016/s0264-410x(03)00505-x
  2. Aldous, E. W., Seekings, J. M., McNally, A., Nili, H., Fuller, C. M., Irvine, R. M., Alexander, D. J., & Brown, I. H. (2010). Infection dynamics of highly pathogenic avian influenza and virulent avian paramyxovirus type 1 viruses in chickens, turkeys and ducks. Avian pathology : journal of the W.V.P.A, 39(4), 265–273. https://doi.org/10.1080/03079457.2010.492825